BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 18797460)

  • 1. The role of endothelial-to-mesenchymal transition in cancer progression.
    Potenta S; Zeisberg E; Kalluri R
    Br J Cancer; 2008 Nov; 99(9):1375-9. PubMed ID: 18797460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of endothelial-mesenchymal transition in development and pathological process.
    Lin F; Wang N; Zhang TC
    IUBMB Life; 2012 Sep; 64(9):717-23. PubMed ID: 22730243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
    Sharma V; Dogra N; Saikia UN; Khullar M
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
    Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
    J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of endothelial cell plasticity by TGF-β.
    van Meeteren LA; ten Dijke P
    Cell Tissue Res; 2012 Jan; 347(1):177-86. PubMed ID: 21866313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EndMT: A promising and controversial field.
    Hong L; Du X; Li W; Mao Y; Sun L; Li X
    Eur J Cell Biol; 2018 Sep; 97(7):493-500. PubMed ID: 30082099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.
    Zeisberg EM; Potenta S; Xie L; Zeisberg M; Kalluri R
    Cancer Res; 2007 Nov; 67(21):10123-8. PubMed ID: 17974953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeleton Reorganization in EndMT-The Role in Cancer and Fibrotic Diseases.
    Ciszewski WM; Wawro ME; Sacewicz-Hofman I; Sobierajska K
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.
    Zeisberg EM; Tarnavski O; Zeisberg M; Dorfman AL; McMullen JR; Gustafsson E; Chandraker A; Yuan X; Pu WT; Roberts AB; Neilson EG; Sayegh MH; Izumo S; Kalluri R
    Nat Med; 2007 Aug; 13(8):952-61. PubMed ID: 17660828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-to-Mesenchymal Transition: Role in Cardiac Fibrosis.
    Cheng W; Li X; Liu D; Cui C; Wang X
    J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):3-11. PubMed ID: 32851865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic potential of targeting the endothelial-to-mesenchymal transition.
    Man S; Sanchez Duffhues G; Ten Dijke P; Baker D
    Angiogenesis; 2019 Feb; 22(1):3-13. PubMed ID: 30076548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2/3-Snail signalling pathway.
    Wang B; Ge Z; Wu Y; Zha Y; Zhang X; Yan Y; Xie Y
    J Cell Mol Med; 2020 Nov; 24(21):12799-12812. PubMed ID: 32945126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
    Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
    Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial-to-Mesenchymal Transition: A Potential Mechanism for Atherosclerosis Plaque Progression and Destabilization.
    Li A; Peng W; Xia X; Li R; Wang Y; Wei D
    DNA Cell Biol; 2017 Nov; 36(11):883-891. PubMed ID: 28920704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition.
    Zhang GH; Yu FC; Li Y; Wei Q; Song SS; Zhou FP; Tong JY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelial-mesenchymal transition (EndMT) and tissue regeneration.
    Yu W; Liu Z; An S; Zhao J; Xiao L; Gou Y; Lin Y; Wang J
    Curr Stem Cell Res Ther; 2014 May; 9(3):196-204. PubMed ID: 24524794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis.
    Cruz-Solbes AS; Youker K
    Results Probl Cell Differ; 2017; 60():345-372. PubMed ID: 28409352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nur77 deficiency exacerbates cardiac fibrosis after myocardial infarction by promoting endothelial-to-mesenchymal transition.
    Chen J; Jia J; Ma L; Li B; Qin Q; Qian J; Ge J
    J Cell Physiol; 2021 Jan; 236(1):495-506. PubMed ID: 32542822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When the endothelium scores an own goal: endothelial cells actively augment metastatic extravasation through endothelial-mesenchymal transition.
    Gasparics Á; Rosivall L; Krizbai IA; Sebe A
    Am J Physiol Heart Circ Physiol; 2016 May; 310(9):H1055-63. PubMed ID: 26993222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts.
    Yeon JH; Jeong HE; Seo H; Cho S; Kim K; Na D; Chung S; Park J; Choi N; Kang JY
    Acta Biomater; 2018 Aug; 76():146-153. PubMed ID: 30078422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.